Quality assessment and response to less invasive surfactant administration (LISA) without sedation.

08:00 EDT 27th August 2019 | BioPortfolio

Summary of "Quality assessment and response to less invasive surfactant administration (LISA) without sedation."

Although sedative premedication for endotracheal intubation is considered standard of care, less invasive surfactant administration (LISA) is often performed without sedative premedication.


Journal Details

This article was published in the following journal.

Name: Pediatric research
ISSN: 1530-0447


DeepDyve research library

PubMed Articles [25867 Associated PubMed Articles listed on BioPortfolio]

Survey of Less Invasive Surfactant Administration in England, slow adoption and variable practice.

National survey to evaluate the uptake of LISA (Less Invasive Surfactant Administration) in neonatal units across England.

The effect of less invasive surfactant administration on cerebral oxygenation in preterm infants.

To determine the regional cerebral tissue oxygenation saturation (rcSO ) in a group of infants requiring less invasive surfactant administration (LISA) as compared to infants with continuous positive ...

Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.

Surfactant administration traditionally involved endotracheal intubation and mechanical ventilation, which is associated with a risk of barotrauma and volutrauma.

Surfactant Administration via Thin Catheter: A Practical Guide.

Exogenous surfactant replacement is the most effective evidence-based therapy for respiratory distress syndrome in preterm infants. The mode of administration has evolved in the last decade towards le...

Cardiorespiratory Physiology following Minimally Invasive Surfactant Therapy in Preterm Infants.

Surfactant replacement therapy through the endotracheal tube has been shown to improve lung compliance and reduce pulmonary pressures. Minimally invasive surfactant therapy (MIST) combines the benefit...

Clinical Trials [16683 Associated Clinical Trials listed on BioPortfolio]

LISA Compared to CPAP in Preterm Infants

This study is being conducted to determine whether early administration of surfactant by the Less Invasive Surfactant Administration (LISA) method reduces the need for mechanical ventilati...

Less Invasive Beractant Administration in Preterm Infants

The aim of this study is to assess the efficacy and feasibility of a new less invasive surfactant administration (LISA) technique with a specific designed cannula for surfactant administra...

LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants

To evaluate the efficacy of less invasive surfactant administration(LISA )technique in the treatment of neonatal respiratory distress syndrome(NRDS) by comparing with the traditional ...

Assessment of Ketamine and Propofol Sedation During LISA Method (Less Invasive Surfactant Administration)

Respiratory distress syndrome (RDS) caused by surfactant deficiency remains one of the major reasons of morbi-mortality in preterm infants and affects 85% of preterm babies born less than ...

A Study in Preterm Neonates With RDS to Compare CUROSURF® Administration Through LISA and Conventional Administration

This study will compare the administration of porcine surfactant (poractant alfa, Curosurf®) through a less invasive method (LISA) using a thin catheter (CHF 6440) during non-invasive ven...

Medical and Biotech [MESH] Definitions

Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps.

A pulmonary surfactant associated protein that plays a role in alveolar stability by lowering the surface tension at the air-liquid interface. It is a membrane-bound protein that constitutes 1-2% of the pulmonary surfactant mass. Pulmonary surfactant-associated protein C is one of the most hydrophobic peptides yet isolated and contains an alpha-helical domain with a central poly-valine segment that binds to phospholipid bilayers.

A pulmonary surfactant associated-protein that plays an essential role in alveolar stability by lowering the surface tension at the air-liquid interface. Inherited deficiency of pulmonary surfactant-associated protein B is one cause of RESPIRATORY DISTRESS SYNDROME, NEWBORN.

A non-invasive assessment of the stability of tissue-embedded prosthetic devices such as dental implants.

An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens and enhances their opsinization and killing by phagocytic cells. Surfactant protein D contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.

Quick Search

DeepDyve research library

Searches Linking to this Article